BaroFold continues to march, achieving milestone after milestone. Congratulations are in order now for striking a process development and cGMP manufacturing agreement for their lead compound BaroFeron™ (interferon beta-1b) with Avecia Biologics.
Avecia will incorporate BaroFold's PreEMT™ hydrostatic pressure technology which enables improved, safer, proprietary protein therapeutics, providing product life-cycle extensions and creating new protein therapeutics through the use of a patented protein refolding technology.
Next up…complete scale-up and the drug manufacturing process.
If you enjoyed this post get free email updates (here).